Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patients
European Journal of Cancer(2023)
摘要
•Baseline ctDNA was not associated with progression free or overall survival (OS).•A change in ctDNA after one cycle of treatment was predictive of survival.•A decrease in ctDNA (T1-2) corresponded with longer OS despite radiological progression.•Low NLR was associated with improved OS.
更多查看译文
关键词
tumour dna kinetics,cancer patients,recurrent/metastatic head
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要